Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
pazopanib (votrient) (1 trial)
Carcinoma (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Trials (1 total)
Trial APIs (1 total)